Why Demonstrated Value Is Not Enough Securing Access in a Constrained Pricing Environment
- Understanding how payer dynamics, account structures, and reimbursement pathways shape access outcomes beyond the strength of clinical and real-world evidence
- Navigating negotiation realities including contracting, channel dynamics, and policy constraints that influence pricing decisions even when value is clearly demonstrated
- Adapting market access strategy to focus on high impact moments that improve coverage and uptake, while balancing evidence generation with commercial and payer expectations